
Analysis
Healthtech funding rebounds to $1.1 billion in Q3 as investors return to diagnostics
Late-stage rounds are back, but investors are writing cheques for profitability, not growth at any cost.
Rohan Malhotra6 min read
Funding, investments, founders and the emerging healthcare businesses to watch.

High customer-acquisition costs are pushing app makers towards enterprise contracts.
8 min read

From AI pathology to rural pharmacies, our editors pick the young companies with the most momentum.
7 min read